Skip to main content

MJFF Publications

2431 - 2440 of 7730 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • RESTRICTED
    Title: Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-021-00848-w
    Citation Count: 8
  • RESTRICTED
    Title: Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.700714
    Citation Count: 22
  • RESTRICTED
    Title: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01256-w
    Citation Count: 3
  • RESTRICTED
    Title: Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00110-x
    Citation Count: 19
  • RESTRICTED
    Title: Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2021.10207
    Citation Count: 87
  • RESTRICTED
    Title: Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-021-00549-x
    Citation Count: 164
  • RESTRICTED
    Title: Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452
    Citation Count: 25
  • RESTRICTED
    Title: Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02367-3
    Citation Count: 33
  • RESTRICTED
    Title: Rare variants in the endocytic pathway are associated with Alzheimer’s disease, its related phenotypes, and functional consequences
    Journal Name: PLOS Genetics
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pgen.1009772
    Citation Count: 1
  • RESTRICTED
    Title: DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13239
    Citation Count: 24
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.